The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Japanese Encephalitis Vaccines Market Research Report 2024

Global Japanese Encephalitis Vaccines Market Research Report 2024

Publishing Date : May, 2024

License Type :
 

Report Code : 1466006

No of Pages : 84

Synopsis
Epidemic encephalitis (JE) is a disease spreads through mosquito bites. Symptoms usually take 5-15 days to develop and include fever, headache, vomiting, confusion, and difficulty moving. The major form of the disease is encephalitis, and less severe forms such as aseptic meningitis or simple fever syndrome with headache are also frequent. The mortality rate of Japanese encephalitis is high, and sequelae are very common, especially among children (up to 50%). Prevention is possible through the use of inactivated vaccines.
The global Japanese Encephalitis Vaccines market was valued at US$ 208.6 million in 2023 and is anticipated to reach US$ 300.3 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Japanese Encephalitis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Japanese Encephalitis Vaccines.
Report Scope
The Japanese Encephalitis Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Japanese Encephalitis Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Japanese Encephalitis Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi Pasteur
GlaxoSmithKline
Bharat Biotech
China National Biotec Group
Valneva Products
Segment by Type
Attenuated Vaccines
Inactivated Vaccines
Segment by Application
Adults
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Japanese Encephalitis Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Japanese Encephalitis Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Japanese Encephalitis Vaccines Market Overview
1.1 Product Overview and Scope of Japanese Encephalitis Vaccines
1.2 Japanese Encephalitis Vaccines Segment by Type
1.2.1 Global Japanese Encephalitis Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.3 Japanese Encephalitis Vaccines Segment by Application
1.3.1 Global Japanese Encephalitis Vaccines Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Children
1.4 Global Japanese Encephalitis Vaccines Market Size Estimates and Forecasts
1.4.1 Global Japanese Encephalitis Vaccines Revenue 2019-2030
1.4.2 Global Japanese Encephalitis Vaccines Sales 2019-2030
1.4.3 Global Japanese Encephalitis Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Japanese Encephalitis Vaccines Market Competition by Manufacturers
2.1 Global Japanese Encephalitis Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Japanese Encephalitis Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Japanese Encephalitis Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Japanese Encephalitis Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Japanese Encephalitis Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Japanese Encephalitis Vaccines, Product Type & Application
2.7 Japanese Encephalitis Vaccines Market Competitive Situation and Trends
2.7.1 Japanese Encephalitis Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Japanese Encephalitis Vaccines Players Market Share by Revenue
2.7.3 Global Japanese Encephalitis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Japanese Encephalitis Vaccines Retrospective Market Scenario by Region
3.1 Global Japanese Encephalitis Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Japanese Encephalitis Vaccines Global Japanese Encephalitis Vaccines Sales by Region: 2019-2030
3.2.1 Global Japanese Encephalitis Vaccines Sales by Region: 2019-2024
3.2.2 Global Japanese Encephalitis Vaccines Sales by Region: 2025-2030
3.3 Global Japanese Encephalitis Vaccines Global Japanese Encephalitis Vaccines Revenue by Region: 2019-2030
3.3.1 Global Japanese Encephalitis Vaccines Revenue by Region: 2019-2024
3.3.2 Global Japanese Encephalitis Vaccines Revenue by Region: 2025-2030
3.4 North America Japanese Encephalitis Vaccines Market Facts & Figures by Country
3.4.1 North America Japanese Encephalitis Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Japanese Encephalitis Vaccines Sales by Country (2019-2030)
3.4.3 North America Japanese Encephalitis Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Japanese Encephalitis Vaccines Market Facts & Figures by Country
3.5.1 Europe Japanese Encephalitis Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Japanese Encephalitis Vaccines Sales by Country (2019-2030)
3.5.3 Europe Japanese Encephalitis Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Japanese Encephalitis Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Japanese Encephalitis Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Japanese Encephalitis Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Japanese Encephalitis Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Japanese Encephalitis Vaccines Market Facts & Figures by Country
3.7.1 Latin America Japanese Encephalitis Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Japanese Encephalitis Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Japanese Encephalitis Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Japanese Encephalitis Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Japanese Encephalitis Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Japanese Encephalitis Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Japanese Encephalitis Vaccines Sales by Type (2019-2030)
4.1.1 Global Japanese Encephalitis Vaccines Sales by Type (2019-2024)
4.1.2 Global Japanese Encephalitis Vaccines Sales by Type (2025-2030)
4.1.3 Global Japanese Encephalitis Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Japanese Encephalitis Vaccines Revenue by Type (2019-2030)
4.2.1 Global Japanese Encephalitis Vaccines Revenue by Type (2019-2024)
4.2.2 Global Japanese Encephalitis Vaccines Revenue by Type (2025-2030)
4.2.3 Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Japanese Encephalitis Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Japanese Encephalitis Vaccines Sales by Application (2019-2030)
5.1.1 Global Japanese Encephalitis Vaccines Sales by Application (2019-2024)
5.1.2 Global Japanese Encephalitis Vaccines Sales by Application (2025-2030)
5.1.3 Global Japanese Encephalitis Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Japanese Encephalitis Vaccines Revenue by Application (2019-2030)
5.2.1 Global Japanese Encephalitis Vaccines Revenue by Application (2019-2024)
5.2.2 Global Japanese Encephalitis Vaccines Revenue by Application (2025-2030)
5.2.3 Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Japanese Encephalitis Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporation Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Japanese Encephalitis Vaccines Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GlaxoSmithKline Japanese Encephalitis Vaccines Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Bharat Biotech
6.3.1 Bharat Biotech Corporation Information
6.3.2 Bharat Biotech Description and Business Overview
6.3.3 Bharat Biotech Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bharat Biotech Japanese Encephalitis Vaccines Product Portfolio
6.3.5 Bharat Biotech Recent Developments/Updates
6.4 China National Biotec Group
6.4.1 China National Biotec Group Corporation Information
6.4.2 China National Biotec Group Description and Business Overview
6.4.3 China National Biotec Group Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 China National Biotec Group Japanese Encephalitis Vaccines Product Portfolio
6.4.5 China National Biotec Group Recent Developments/Updates
6.5 Valneva Products
6.5.1 Valneva Products Corporation Information
6.5.2 Valneva Products Description and Business Overview
6.5.3 Valneva Products Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Valneva Products Japanese Encephalitis Vaccines Product Portfolio
6.5.5 Valneva Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Japanese Encephalitis Vaccines Industry Chain Analysis
7.2 Japanese Encephalitis Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Japanese Encephalitis Vaccines Production Mode & Process
7.4 Japanese Encephalitis Vaccines Sales and Marketing
7.4.1 Japanese Encephalitis Vaccines Sales Channels
7.4.2 Japanese Encephalitis Vaccines Distributors
7.5 Japanese Encephalitis Vaccines Customers
8 Japanese Encephalitis Vaccines Market Dynamics
8.1 Japanese Encephalitis Vaccines Industry Trends
8.2 Japanese Encephalitis Vaccines Market Drivers
8.3 Japanese Encephalitis Vaccines Market Challenges
8.4 Japanese Encephalitis Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Japanese Encephalitis Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Japanese Encephalitis Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Japanese Encephalitis Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Japanese Encephalitis Vaccines Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Japanese Encephalitis Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Japanese Encephalitis Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Japanese Encephalitis Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Japanese Encephalitis Vaccines Average Price (USD/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Japanese Encephalitis Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Japanese Encephalitis Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Japanese Encephalitis Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Japanese Encephalitis Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Japanese Encephalitis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Japanese Encephalitis Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Japanese Encephalitis Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Japanese Encephalitis Vaccines Sales by Region (2019-2024) & (K Doses)
Table 18. Global Japanese Encephalitis Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Japanese Encephalitis Vaccines Sales by Region (2025-2030) & (K Doses)
Table 20. Global Japanese Encephalitis Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Japanese Encephalitis Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Japanese Encephalitis Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Japanese Encephalitis Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Japanese Encephalitis Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Japanese Encephalitis Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Japanese Encephalitis Vaccines Sales by Country (2019-2024) & (K Doses)
Table 27. North America Japanese Encephalitis Vaccines Sales by Country (2025-2030) & (K Doses)
Table 28. North America Japanese Encephalitis Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Japanese Encephalitis Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Japanese Encephalitis Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Japanese Encephalitis Vaccines Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Japanese Encephalitis Vaccines Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Japanese Encephalitis Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Japanese Encephalitis Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Japanese Encephalitis Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Japanese Encephalitis Vaccines Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Japanese Encephalitis Vaccines Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Japanese Encephalitis Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Japanese Encephalitis Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Japanese Encephalitis Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Japanese Encephalitis Vaccines Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Japanese Encephalitis Vaccines Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Japanese Encephalitis Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Japanese Encephalitis Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Japanese Encephalitis Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Japanese Encephalitis Vaccines Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Japanese Encephalitis Vaccines Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Japanese Encephalitis Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Japanese Encephalitis Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Japanese Encephalitis Vaccines Sales (K Doses) by Type (2019-2024)
Table 51. Global Japanese Encephalitis Vaccines Sales (K Doses) by Type (2025-2030)
Table 52. Global Japanese Encephalitis Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Japanese Encephalitis Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Japanese Encephalitis Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Japanese Encephalitis Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Japanese Encephalitis Vaccines Price (USD/Dose) by Type (2019-2024)
Table 59. Global Japanese Encephalitis Vaccines Price (USD/Dose) by Type (2025-2030)
Table 60. Global Japanese Encephalitis Vaccines Sales (K Doses) by Application (2019-2024)
Table 61. Global Japanese Encephalitis Vaccines Sales (K Doses) by Application (2025-2030)
Table 62. Global Japanese Encephalitis Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Japanese Encephalitis Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Japanese Encephalitis Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Japanese Encephalitis Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Japanese Encephalitis Vaccines Price (USD/Dose) by Application (2019-2024)
Table 69. Global Japanese Encephalitis Vaccines Price (USD/Dose) by Application (2025-2030)
Table 70. Sanofi Pasteur Corporation Information
Table 71. Sanofi Pasteur Description and Business Overview
Table 72. Sanofi Pasteur Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. Sanofi Pasteur Japanese Encephalitis Vaccines Product
Table 74. Sanofi Pasteur Recent Developments/Updates
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Business Overview
Table 77. GlaxoSmithKline Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. GlaxoSmithKline Japanese Encephalitis Vaccines Product
Table 79. GlaxoSmithKline Recent Developments/Updates
Table 80. Bharat Biotech Corporation Information
Table 81. Bharat Biotech Description and Business Overview
Table 82. Bharat Biotech Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Bharat Biotech Japanese Encephalitis Vaccines Product
Table 84. Bharat Biotech Recent Developments/Updates
Table 85. China National Biotec Group Corporation Information
Table 86. China National Biotec Group Description and Business Overview
Table 87. China National Biotec Group Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. China National Biotec Group Japanese Encephalitis Vaccines Product
Table 89. China National Biotec Group Recent Developments/Updates
Table 90. Valneva Products Corporation Information
Table 91. Valneva Products Description and Business Overview
Table 92. Valneva Products Japanese Encephalitis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. Valneva Products Japanese Encephalitis Vaccines Product
Table 94. Valneva Products Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Japanese Encephalitis Vaccines Distributors List
Table 98. Japanese Encephalitis Vaccines Customers List
Table 99. Japanese Encephalitis Vaccines Market Trends
Table 100. Japanese Encephalitis Vaccines Market Drivers
Table 101. Japanese Encephalitis Vaccines Market Challenges
Table 102. Japanese Encephalitis Vaccines Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Japanese Encephalitis Vaccines
Figure 2. Global Japanese Encephalitis Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Japanese Encephalitis Vaccines Market Share by Type in 2023 & 2030
Figure 4. Attenuated Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Global Japanese Encephalitis Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Japanese Encephalitis Vaccines Market Share by Application in 2023 & 2030
Figure 8. Adults
Figure 9. Children
Figure 10. Global Japanese Encephalitis Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Japanese Encephalitis Vaccines Market Size (2019-2030) & (US$ Million)
Figure 12. Global Japanese Encephalitis Vaccines Sales (2019-2030) & (K Doses)
Figure 13. Global Japanese Encephalitis Vaccines Average Price (USD/Dose) & (2019-2030)
Figure 14. Japanese Encephalitis Vaccines Report Years Considered
Figure 15. Japanese Encephalitis Vaccines Sales Share by Manufacturers in 2023
Figure 16. Global Japanese Encephalitis Vaccines Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Japanese Encephalitis Vaccines Players: Market Share by Revenue in 2023
Figure 18. Japanese Encephalitis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Japanese Encephalitis Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Japanese Encephalitis Vaccines Sales Market Share by Country (2019-2030)
Figure 21. North America Japanese Encephalitis Vaccines Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Japanese Encephalitis Vaccines Sales Market Share by Country (2019-2030)
Figure 25. Europe Japanese Encephalitis Vaccines Revenue Market Share by Country (2019-2030)
Figure 26. Germany Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Japanese Encephalitis Vaccines Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Japanese Encephalitis Vaccines Revenue Market Share by Region (2019-2030)
Figure 33. China Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Japanese Encephalitis Vaccines Sales Market Share by Country (2019-2030)
Figure 44. Latin America Japanese Encephalitis Vaccines Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Japanese Encephalitis Vaccines Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Japanese Encephalitis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Japanese Encephalitis Vaccines by Type (2019-2030)
Figure 54. Global Revenue Market Share of Japanese Encephalitis Vaccines by Type (2019-2030)
Figure 55. Global Japanese Encephalitis Vaccines Price (USD/Dose) by Type (2019-2030)
Figure 56. Global Sales Market Share of Japanese Encephalitis Vaccines by Application (2019-2030)
Figure 57. Global Revenue Market Share of Japanese Encephalitis Vaccines by Application (2019-2030)
Figure 58. Global Japanese Encephalitis Vaccines Price (USD/Dose) by Application (2019-2030)
Figure 59. Japanese Encephalitis Vaccines Value Chain
Figure 60. Japanese Encephalitis Vaccines Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’